你即將離開本站

並前往https://www.pharmtech.com/view/nice-recommends-forxiga-for-marketing-authorization

NICE Recommends Forxiga for Marketing Authorization

... marketing authorization for AstraZeneca's chronic kidney disease treatment, ... is based on results from the DAPA-CKD Phase III trial.

確定！ 回上一頁

查詢 「DAPA-CKD trial」的人也找了：

  1. dapa-ckd trial ppt
    2.
  2. Dapagliflozin hemodialysis
    3.
  3. EMPA CKD
    4.
  4. dapa ckd中文
    5.
  5. CREDENCE trial
    6.
  6. Dapa ckd trial wiki
    7.
  7. Empagliflozin CKD
    8.
  8. DECLARE-TIMI 58
    9.